Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium augmentation versus phenelzine for treatment-resistant depression in older inpatients
NL-OMON28173Active, not recruiting
- Sponsor
- ZonMw
- Start
- Jan 2000
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial in major depressive disorder (MDD) comparing Phenelzine arm with Lithium augmentation arm (2 arms). Primary endpoints: Remission on MADRS and Global Tolerability Score. Started Jan 2000; status: active, not recruiting.
02
Drugs
phenelzinelithium carbonate
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON28173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28173.